Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Solid Biosciences Inc. (SLDB) had Normalized Pre-Tax Income of $-39.48M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-39.48M |
|
-- |
|
-- |
|
$41.69M |
|
$-41.69M |
|
$2.21M |
|
$-39.48M |
|
|
Normalized Pre-Tax Income |
$-39.48M |
$-39.48M |
|
$-39.48M |
|
$-39.48M |
|
$-39.48M |
|
$-41.69M |
|
$-41.80M |
|
94.14M |
|
94.14M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$278.64M |
|
$4.32M |
|
$29.65M |
|
$308.29M |
|
$29.85M |
|
-- |
|
$20.16M |
|
$50.00M |
|
$258.29M |
|
$258.29M |
|
$258.29M |
|
77.60M |
|
| Cash Flow Statement Financials | |
$-69.26M |
|
$-60.20M |
|
$188.13M |
|
$82.19M |
|
$140.86M |
|
$58.67M |
|
$6.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.34 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-69.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.29% |
|
-15.29% |
|
-12.81% |
|
-15.29% |
|
$3.33 |
|
$-0.74 |
|
$-0.74 |
|